Background: A unified set of criteria for neurocysticercosis (NCC) has helped to standardize its diagnosis in different settings.
Introduction
Despite being caused by a well-known infective agent -the encysted larval stage of the pork tapeworm Taenia solium -the diagnosis of neurocysticercosis (NCC) is complicated because histological demonstration of the parasites is not possible, as surgical resection of the lesion is not indicated in most cases. During the second half of the 20 th century, introduction of modern neuroimaging techniques and development of immunological tests enhanced the diagnostic accuracy for NCC by allowing visualization of parasites within the central nervous system and demonstrating specific host antibodies and parasite antigens [1] .
Nevertheless, the diagnosis remained problematic as neuroimaging findings are rarely pathognomonic and immunodiagnostic tests vary in sensitivity and specificity [2, 3] . An initial proposal for a set of diagnostic criteria for human cysticercosis (both systemic cysticercosis and NCC) based on the objective evaluation of clinical, radiologic, immunologic, and epidemiologic data was published in 1996 [4] . An updated version was proposed in 2001, confined to the diagnosis of NCC [5] . Both sets used the same basic structure, that is, four categories of diagnostic criteria (absolute, major, minor and epidemiologic) stratified according to their diagnostic strength, and different degrees of diagnostic certainty based on the likelihood that the disease is present in a given patient.
These criteria have proved useful for NCC diagnosis in both hospital and field settings, have been widely used in endemic as well as in non-endemic areas [6] , and have recently been validated by an external group, with a sensitivity of 93.6% and a specificity of 81.1%
for the diagnosis of NCC [7] . Here, we present a revised version of the set of diagnostic criteria for NCC, updated to provide simpler and more operational definitions, as well as to incorporate advances and insights that have improved the diagnosis in recent years.
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Conceptual basis for updates and modifications
As was the case in the 2001 set of diagnostic criteria, this revised version is designed for the diagnosis of NCC, because -with few exceptions -subcutaneous, muscular or other forms of systemic cysticercosis are not significant medical problems. A second guiding principle was to ensure its worldwide applicability, irrespective of the reported regional differences in the forms of presentation or NCC.
Methodology:
A panel of experts in human cysticercosis was convened, including neurologists, neurosurgeons, neuroradiologists, parasitologists, infectious disease specialists and epidemiologists from Latin America, the Indian subcontinent, and the United States (US). An initial step identified criteria that were unanimously considered appropriate and selected those targeted for modification or exclusion. Relevant literature on recent advances in the diagnosis of this disease was independently reviewed by panel members. The opinions of each of the experts were used to draft a modified version of the diagnostic criteria chart. Discrepancies were resolved by discussion and consensus. As the primary focus of this manuscript was not to report the findings of an accuracy study, schemes such as the STARD guidelines [8] were not used.
Overview of major modifications:
While the category of absolute diagnostic criteria remains essentially unchanged in this revised version, the structure of the remaining categories was modified in accordance with to two main principles: 1) neuroimaging studies are essential for the diagnosis of NCC; and 2) information from clinical manifestations, immunodiagnostic tests and epidemiologic settings only provides indirect evidence favoring the diagnosis of NCC. Therefore, instead of having categories of major, minor and epidemiologic criteria, where different types of criteria were grouped according
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to their individual diagnostic strength, we now use neuroimaging signatures of NCC on one side and clinical/exposure evidence for cysticercosis on the other. As a result, the requirements for a case being classified as "definitive" or "probable" NCC changed according to these principles (Table 1) .
Revised diagnostic criteria
3.1. Absolute diagnostic criteria: These criteria provide unequivocal evidence of the presence of cysticerci infection of the central nervous system (Figure 1 ).
Histological demonstration of the parasite from biopsy of a brain or spinal cord
lesion: Visualization of histopathological characteristics of cysticerci in biopsy material, including the spiral canal and the rostellum with its four suckers and the double crown of hooks, confirm the diagnosis of NCC [9] . In many subarachnoid cysts, the scolex cannot be identified but the typical three-layered membrane wall often allows the correct identification of the parasite. However, a problem arises when biopsy material comes from calcified or even granular cysticerci since the scolex and membranes may not be present in these stages of involution of parasites. In such cases, the presence of the so-called calcareous corpuscles may help to identify the parasitic (cestode) nature of the lesion [10] .
Visualization of subretinal cysticercus:
Fundoscopic examination revealing the characteristic appearance of subretinal cysticerci allows definitive diagnosis of NCC as the retina is part of the central nervous system [11, 12] . These lesions are unusual, even in endemic areas, and may or may not be associated with cerebral lesions. Of note, individuals A C C E P T E D M A N U S C R I P T
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with cysticerci located in the anterior chamber of the eye should not be considered to have NCC but cysticercosis outside the nervous system.
3.1.3.
Conclusive demonstration of a scolex within a cystic lesion on neuroimaging studies: These lesions were described in the first reports of neuroimaging findings of NCC, and are known to represent living parenchymal, small subarachnoid or ventricular cysticerci [13, 14] . Parenchymal cysts tend to develop at the cortical-subcortical junction and the basal ganglia, and less often located in the brainstem, cerebellum or the spinal cord parenchyma.
Subarachnoid cysts showing the scolex are often those located within cortical sulci at the convexity of cerebral hemispheres, and ventricular cysts may be located within any ventricular cavity.
Signal properties of the scolex components allow its brilliant appearance on CT and MRI, producing the so-called "hole-with-dot" imaging that has long been reported as pathognomonic of NCC [14] . New protocols such as diffusion weighted images (DWI) and fast imaging employing steady-state acquisition (FIESTA) may enhance the diagnostic accuracy of MRI as they allow the recognition of the scolex in cases that are not visualized with conventional sequences [15, 16] 
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diameter, round and clearly demarcated from the surrounding brain parenchyma, and do not significantly enhance after contrast medium administration.
Neuroimaging criteria:
Some neuroimaging signatures of NCC strongly suggest the diagnosis but should not be used by themselves to confirm the presence of the disease ( Figure 4 ). In the present version, neuroimaging criteria are separately considered to reflect the importance of their combination for reaching a definitive diagnosis of NCC.
Nevertheless, it must be kept in mind that several other conditions may cause this type of lesions and a diagnostic work-up attempting to discard alternative pathologies is advised. cavities. These lesions are often well demarcated from the surrounding cerebral tissues and most of them do not show abnormal enhancement after contrast medium administration [17] . When cysts are multiple and located in the brain parenchyma and/or in subcortical sulci between two cerebral convolutions, they give the brain a "Swiss cheese" appearance, which is fairly characteristic of NCC [18] .
Major neuroimaging criteria:
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Enhancing lesions:
This category includes some of the most common, but at the same time less specific, neuroimaging signatures of NCC [19] . These lesions are usually <20mm in diameter and display enhancement in a ring or nodular pattern after contrast medium administration. These lesions may or may not be surrounded by edema but rarely displace midline structures [20] . Some of them may have imaging evidence of a cystic cavity filled with fluid while others appear more ill-defined and compact. These lesions may be single or multiple and may be located in the brain or spinal cord parenchyma, or in the subarachnoid space over the convexity of cerebral hemispheres [19] [20] [21] . Cysts within the ventricular cavities may also present with abnormal enhancement if they are attached to the ventricular lining [19] . To be included into this category, patients with enhancing lesions should fulfill the criteria of Rajshekhar & Chandy (seizures as presenting complaint; no evidence of persistent raised intracranial pressure, progressive neurological deficit or an active systemic disease, and a solitary contrast enhancing lesion measuring 20 mm or less in its maximal dimension without a shift of the midline structures due to the surrounding edema) [20] .
Multilobulated cystic lesions in the subarachnoid space:
Cysticerci-related cystic lesions may attain a large size especially when they are located within the Sylvian fissure, subarachnoid cisterns at the base of the brain and the spinal canal [17, 22, 23] . In these cases -corresponding to the time-honored description of racemose cysticercosis [24] -the scolex is usually not discernible on neuroimaging studies (or even at biopsy, where only degenerated membranes can be seen) as it has been destroyed as the result of a process of hydropic degeneration [9, 19] . Large subarachnoid cysts often adopt a multilobulated
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appearance due to the confluence of vesicles together with inflamed arachnoid membranes; this imaging resembling a "bunch of grapes" is highly suggestive of NCC [23] .
Typical parenchymal brain calcifications:
This is the most common neuroimaging signature of NCC, particularly in areas where the disease is highly endemic [25] . Epidemiological evidence as well as follow up imaging studies in patients after
resolution of viable cysticercosis demonstrate typical calcified lesions, different in shape, size and distribution to brain calcifications resulting from other pathologies. Cysticercirelated calcifications are solid, most often <10mm in diameter and are evenly distributed in the brain parenchyma with the exception of the brainstem and cerebellum, where they are rare. These small, rounded, well-defined calcifications are infrequent if ever found in patients from non cysticercosis-endemic countries, where calcifications due to many other physiological or pathological mechanisms have distinct appearances and shapes [26, 27] .
While modern sequences such as T2-weighted gradient-echo and diffusion tensor imaging have increased the ability of MRI to recognize mineralization, CT should be the optimal screening procedure to visualize calcification and quantify these lesions and to reduce the risk of confusing them with cerebral microbleeds, which is a common unrelated neuroimaging finding in older individuals [28] . On CT, the presence of multiple calcifications gives the brain a "starry night" appearance, which is highly suggestive of NCC.
Confirmative neuroimaging criteria (on follow-up):
For patients presenting with any of the previously described cystic lesions, resolution or transformation into a calcified nodule after a trial with either albendazole or praziquantel [29] , in the absence of any other specific medical treatment, should be considered as a criteria providing robust support for
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NCC diagnosis. In addition, in the subset of patients presenting with a small enhancing lesion fulfilling the imaging criteria of Rajshekhar & Chandy [20] , spontaneous disappearance of these lesions should also be considered as a proof of NCC diagnosis [30, 31] . Spontaneous resolution of single enhancing lesions has long been recognized as a confirmation of NCC [32] , and is not expected to occur in the most frequent potential differential diagnoses such as tuberculosis, toxoplasmosis, malignancy or pyogenic cerebral abscess. It must be kept in mind that corticosteroids are often used as the single therapeutic approach to patients with small enhancing lesions [33] . Since corticosteroids may also favor the resolution of enhancing lesions from unrelated causes (i.e., primary cerebral lymphoma), their administration preclude the use of this particular criterion to confirm NCC diagnosis.
Another confirmative neuroimaging criteria is the demonstration, on sequential neuroimaging studies, of migration of cystic lesions from one ventricular cavity to another (i.e., from the III to the IV ventricle through the cerebral aqueduct), or even within the same cavity (i.e., from the temporal to the occipital horn of a lateral ventricle or from the anterior to the posterior aspects of the III ventricle). This migration may occur when cysts are freely-floating within the ventricular system and, although rare, is virtually pathognomonic of NCC [34] [35] [36] [37] .
Minor neuroimaging criteria:
These criteria refer to lesions compatible with NCC on neuroimaging studies, including obstructive hydrocephalus (symmetrical or asymmetrical) and focal or diffuse abnormal enhancement of the leptomeninges at the base of the brain. These findings provide additional support for the diagnosis of NCC in patients with a single major neuroimaging criterion but, by themselves, are non-specific as they are
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often observed in other infectious and non-infectious diseases of the nervous system. In this scenario, cytochemical analysis of CSF may provide diagnostic clues that must be interpreted on the light of the clinical manifestations and the results of other complementary exams.
Clinical/exposure criteria:
All criteria included under this category refer to findings strongly favoring or confirming the diagnosis of cysticercosis, which may not necessarily be located in the nervous system. As previously noticed, the presence of any of them should only be used as a circumstantial evidence favoring the diagnosis of NCC.
Detection of specific anticysticercal antibodies or cysticercal antigens by wellstandardized immunodiagnostic tests:
The enzyme-linked immunoelectrotransfer blot (EITB) assay using lentil lectin-purified glycoprotein extracts is the most reliable test for the detection of antibodies specific for T. solium antigens in serum or CSF [38] . This EITB has a specificity approaching 100% and a sensitivity of 98% for individuals with two or more viable or degenerating parasites [39] , although a single positive reaction with the 50kDa protein occasionally represents a false-positive result [40] . Furthermore, a positive EITB does not confirm CNS infection since it demonstrates a systemic antibody response.
It should be taken into account that in endemic regions there is a sizable positive background seroprevalence of 5-20%, usually with weak reactions to one or a few bands [25] . Another limitation of the EITB is its low sensitivity in patients with single intracranial cysticerci and in those with only calcified parasites, where up to 50% of cases may be falsely negative [41, 42] .
The use of a monoclonal antibody (MAb)-based ELISA for detection of cysticercal antigen in serum or CSF reflects the presence of viable parasites and has been reported to be very
A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT
useful, particularly in the follow up of NCC patients [43] . The sensitivity of this test has not been assessed in detail, although it seems lower than antibody tests in patients with one or a few lesions [38] . This assay is nearly always negative in individuals with calcified parasites only. While it does not seem to cross-react with any of the other known human cestode infections, interpretation of a positive test is likely affected by the selection of a lower (less specific) or higher cut-off. So far, the high numbers of antigen-positive individuals in community-based studies in Africa have not been systematically confirmed by brain imaging [44] .
Some time-honored tests, such as anticysticercal antibody detection by ELISA in CSF samples [45] , have shown to be reliable for the diagnosis of some forms of NCC and are still used as a diagnostic tool in areas with limited access to the EITB assay. However, the multiplicity of crude and semi-purified antigens used in diverse assays in the absence of verification and standardization does not allow a general acceptance of its use [46] .
Although some ELISAs using new antigens are reported in the literature, none of these assays is commercially available; on the contrary, published examples demonstrate how cross reactions in ELISA may lead to wrong diagnoses and worsen the patient's prognosis [47, 48] . Therefore, at the present time antibody-detection by ELISA should not be included as a diagnostic criterion
Cysticercosis outside the nervous system:
The presence of extraneural cysticercosis requires histological demonstration of the parasite from biopsy of a subcutaneous nodule, plain X-ray films or CT scans showing multiple "cigar-shaped" calcifications in thigh and calf muscles, or direct visualization of a cysticercus in the anterior chamber of the eye.
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Evidence of a household contact with T. solium infection:
The finding of a Taenia carrier in the patient's close environment is now considered highly suggestive of exposure in light of robust evidence showing cysticercosis is commonly transmitted from human-tohuman and clustered in households [49] . Indeed, compulsory search of Taenia carriers among household contacts of NCC patients is currently advised to identify the potential source of infection, and to reduce further spread of the disease [38] .
Presence of clinical manifestations suggestive of NCC:
Symptomatic NCC patients often present with non-specific findings that might not be used as a strong argument favoring the diagnosis. Seizures are the most common manifestation, occurring in 70% of symptomatic cases [50] and are frequently of late onset (in most cases symptoms begin between 20 and 49 years of age) [51] , although they may occur at any age. However, even in this age range, there a number of alternative causes of seizures. Other clinical manifestations of the disease include headache, focal neurologic deficits, intracranial hypertension, and cognitive decline. The prevalence of NCC-related headache and cognitive decline are largely unknown. Focal neurological signs are uncommon and depend on the location of parasites in the nervous system or the occurrence of a cysticercosisrelated stroke, and intracranial hypertension is mainly confined to individuals with hydrocephalus, cysticercotic encephalitis and to those with large subarachnoid or ventricular cysts [52, 53] . Of interest, fever, sweats and weight loss are uncommon manifestation of NCC and its presence should suggest other diagnoses. In addition, the findings of adenopathy suggest an alternative diagnosis such as a tumor or another infection.
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Individuals coming from or living in cysticercosis-endemic areas:
Caution must be exerted when applying this criterion to avoid overdiagnosis just because a person has lived in a country where the disease is common. Endemic areas for cysticercosis should be defined as those places where the life cycle of Taenia solium can be fully completed, as all the inter-related steps needed for its completion are present [54] . It is well known that even within the same country, endemicity of the disease varies between urban centers and rural villages [55] .
Degrees of diagnostic certainty
As previously noticed, evidence needed to reach diagnostic categories of "definitive" and "probable" have been modified according to the changes made in diagnostic criteria.
Definitive diagnosis:
Besides individuals having one absolute criterion, this revised set allows this degree of diagnostic certainty in people having at least two major neuroimaging criteria (or one major plus one confirmative neuroimaging criteria) plus any clinical/exposure criteria. For patients presenting with one major criterion (associated or not with one minor neuroimaging criteria) plus evidence of exposure, definitive diagnosis of NCC requires a complete work-up to exclude confounding pathologies.
Probable diagnosis:
This category includes individuals presenting with only one type of major or minor neuroimaging criteria plus strong evidence of exposure (at least two clinical/exposure criteria). In addition, a probable NCC diagnosis can be entertained in individuals who have not undergone neuroimaging studies yet, provided they have seizures plus at least two other exposure criteria. Of importance, the presence of both a normal CT
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and MRI should negate the diagnosis of NCC even if other clinical/exposure criteria pointing to systemic cysticercosis are present. In the absence of neuroimaging, history of seizures plus at least two other exposure criteria could suggest NCC, but the lack of neuroimaging exams precludes clinical interventions beyond symptomatic measures.
Additional evaluations
After the submission of the initial version of this manuscript, a slightly modified set of criteria was published by a separate group [7] , and reported to have similar sensitivity (93.2%) and specificity (81.4%) as the 2001 version of this set of criteria (sensitivity 93.6%
and specificity 81.1% in the same report). Modifications from the previous version of our criteria included the allocation of a separate category for extraparenchymal NCC, and the inclusion of serum antibody detection by ELISA in the same category than EITB, which has not been considered appropriate [46] .
To assess whether the current set could miss sensitivity for cases of extraparenchymal A total of 21 papers describing 29 patients, where case descriptions and neuroimaging findings were appropriately detailed as to apply our set to diagnostic criteria, were found [35, 37, [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] . Despite the fact that most of these patients did not had a serum EITB performed, the set allowed a definitive pre-operative diagnosis of NCC in 23 cases (one absolute criterion in 12, two major neuroimaging in six, and one major neuroimaging plus one confirmative in five), and a probable diagnosis in the remaining six patients.
Additionally, we evaluated two commercially available ELISA kits (Ridascreen T. solium confirming our position that it should not be equaled to the LLGP-EITB assay as has been suggested by others [7] .
In an ideal scenario, this revised set would be validated to define its accuracy, meaning that individuals falling in the category of definitive NCC diagnosis must undergo invasive procedures to confirm the infection or rule out alternative pathologies, and also a similar number of individuals with a negative NCC diagnosis should undergo these procedures to prove the opposite. Obviously, this is not ethical or even possible for most cases, although partial information can be obtained from systematic long-term follow-up of patients with definitive diagnosis of NCC according to this set, that eventually arrive to a diagnosis other than NCC. Neuroimaging criteria:
Major neuroimaging criteria: 
